HYTN Innovations Inc (HYTN) AI Stock Analysis

• Market Cap: C$18.18M
• Dividend Yield: N/A
• Average Volume (3M): 29.39K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.03
• Revenue Growth: 27.88%
• EPS Growth: -164.47%
• Country: CA
• Employees: 7
• Sector: Technology
• Sector Strength: 45
• Industry: Beverages - Alcoholic
• EPS (TTM): -0.08
• Shares Outstanding: 90,908,090
• 10 Day Avg. Volume: 35,049
• 30 Day Avg. Volume: 29,395
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 21.54
• Price to Cash Flow (P/CF): 11.40
• P/FCF Ratio: 9.20
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

HYTN Innovations Inc. struggles with severe financial instability, characterized by negative equity and cash flow challenges. While technical indicators suggest bearish momentum, the stock's valuation metrics are also unfavorable. However, the company's recent strategic partnerships and international initiatives offer a glimmer of hope for future improvement. The overall score reflects the current financial distress and technical weakness, partially offset by positive corporate developments.

HYTN Innovations Inc Business Overview & Revenue Model

Company Description

HYTN Innovations Inc (HYTN) is a Canadian company operating in the cannabis industry, focusing on the development and production of infused beverages. The company leverages advanced technologies to create innovative cannabis-infused drinks, providing consumers with a diverse range of high-quality, consistent, and enjoyable products. HYTN aims to cater to the growing demand for alternative cannabis consumption methods, emphasizing product quality and consumer experience.

How the Company Makes Money

HYTN Innovations Inc generates revenue primarily through the sale of its cannabis-infused beverages. The company's revenue model is based on manufacturing and distributing these products to licensed retailers and distributors across various regions. HYTN may also engage in strategic partnerships and collaborations with other companies in the cannabis sector to expand its market reach and product offerings. Additionally, the company might invest in research and development to innovate and improve its product line, potentially leading to new revenue streams in the future. HYTN's earnings are influenced by factors such as consumer demand, regulatory changes, and market trends within the cannabis industry.

HYTN Innovations Inc Financial Statement Overview

Summary

HYTN Innovations Inc. is facing significant financial challenges, with modest revenue growth but ongoing profitability issues. The negative equity and high debt-to-equity ratio highlight financial distress, while negative free cash flow indicates liquidity constraints.

Income Statement

HYTN Innovations Inc. has experienced modest revenue growth of 11.52% in the most recent year. However, the company continues to face significant challenges with profitability, as evidenced by negative net income and EBIT margins. This suggests ongoing operational struggles and high costs relative to revenue.

Balance Sheet

The company's balance sheet reflects a negative stockholders' equity, indicating financial distress and potential insolvency risks. The high debt-to-equity ratio, due to negative equity, further emphasizes financial instability. Asset levels are declining, signaling potential liquidity issues.

Cash Flow

HYTN's cash flow statements show negative free cash flow, though there was a slight improvement in operating cash flow. The company's ability to convert net income to cash flows is weak, posing challenges in sustaining operations without external financing.

Breakdown
Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2019
Income Statement		Total Revenue
851.49K	763.46K	696.36K	0.00	0.00
	Gross Profit
287.44K	91.85K	121.65K	0.00	-1.12K
	EBIT
-2.69M	-1.67M	-3.04M	-782.19K	-311.69K
	EBITDA
-6.26M	-1.45M	-9.88M	-745.51K	-310.99K
	Net Income Common Stockholders
-6.61M	-2.33M	-17.38M	-959.48K	-311.66K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
256.58K	187.56K	1.03M	264.06K	271.16K
	Total Assets
2.38M	2.58M	3.79M	2.76M	507.25K
	Total Debt
793.56K	919.74K	887.22K	2.58M	41.98K
	Net Debt
536.98K	732.18K	-139.14K	2.31M	-229.18K
	Total Liabilities
2.56M	2.27M	1.71M	2.77M	18.41K
	Stockholders Equity
-172.97K	314.72K	2.07M	-8.88K	488.85K
Cash Flow		Free Cash Flow
-804.21K	-1.18M	-2.38M	-1.67M	-409.37K
	Operating Cash Flow
-783.36K	-1.18M	-2.16M	-693.52K	-311.08K
	Investing Cash Flow
162.67K	-4.10K	2.19M	-1.02M	-98.29K
	Financing Cash Flow
689.71K	346.17K	727.93K	1.80M	700.53K

HYTN Innovations Inc Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.20
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:HYTN, the sentiment is Negative. The current price of 0.2 is below the 20-day moving average (MA) of 0.27, below the 50-day MA of 0.32, and below the 200-day MA of 0.30, indicating a bearish trend. The MACD of -0.04 indicates Positive momentum. The RSI at 32.41 is Neutral, neither overbought nor oversold. The STOCH value of 4.25 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:HYTN.

HYTN Innovations Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	58 Neutral	$21.35B	9.96	-19.72%	2.38%	5.03%	-22.83%
LABS	51 Neutral	$33.21M	―	-23.66%	―	32.16%	39.05%
HYTN	37 Underperform	C$18.18M	―	-9358.55%	―	27.88%	-164.47%

HYTN Innovations Inc Corporate Events

HYTN Innovations Expands International Footprint with New GMP Initiatives

HYTN Innovations Inc. has launched a Good Manufacturing Practice (GMP) Stability Program and validated its vape cartridges for international distribution, marking a significant step in its partnership with SNDL Inc. This initiative aims to meet regulatory requirements in key global markets and enhance product stability. Additionally, HYTN is expanding its GMP product portfolio by seeking amendments to its licensing framework with Health Canada to include oil-based products. These efforts are designed to strengthen HYTN’s position in the growing global medical cannabis market, particularly in Germany, which has seen a substantial increase in cannabis imports due to rising demand.

HYTN Innovations and A1 Cannabis Collaborate to Expand Cannabis Beverage Market

HYTN Innovations Inc. has entered into a collaboration with A1 Cannabis Inc. to enhance operational efficiency and expand in the cannabis beverage market. The agreement allows for the transition of A1’s product portfolio to HYTN, with A1 providing sales management services. This partnership is expected to accelerate product development, optimize market reach, and drive revenue growth for both companies. While HYTN will handle registration, manufacturing, and sales, A1 retains its brand rights and product formulations.

HYTN and SNDL Team Up for GMP-Compliant Vape Cartridge Development

HYTN Innovations Inc. has announced a collaboration with SNDL Inc. to develop Good Manufacturing Practices (GMP) compliant vape cartridges for global markets. This partnership capitalizes on HYTN’s GMP-certified facility and quality systems expertise while utilizing SNDL’s equipment, consumables, and capital to meet regulatory requirements. The collaboration aligns with the increasing demand for GMP-compliant cannabis vape products, especially in markets like the UK and Germany, highlighting HYTN’s strategic focus on international distribution.

HYTN Expands Global Footprint with New Cannabis Export Permits

HYTN Innovations Inc. has secured import permits from the UK and export permits from Health Canada to expand its international exports of Good Manufacturing Practice (GMP) cannabis products, amounting to over 400 kilograms. This move signifies HYTN’s strategic shift from a Canadian recreational cannabis producer to a global manufacturer of non-sterile pharmaceuticals, aligning with its commitment to meeting GMP standards and catering to the demands of regulated markets worldwide.

HYTN Innovations Secures Initial Order in Global Cannabis Expansion

HYTN Innovations Inc. announced the receipt of an initial purchase order under its partnership with SNDL Inc., a major player in the cannabis industry. This collaboration, which involves using EU Good Manufacturing Practice standards, aims to enhance their presence in the international cannabis market. The partnership highlights HYTN’s ability to produce high-volume, EU GMP-certified cannabis and supports SNDL’s expansion into global markets. The agreement positions both companies to capitalize on the growing global cannabis industry, with significant opportunities in regions like Germany and Australia.

HYTN Innovations Expands Cannabis Exports to UK

HYTN Innovations Inc. has successfully exported its first shipment of medical cannabis to the UK, marking a significant step in its international expansion strategy. Following this initial success, the company has received additional orders for over 500 kilograms of cannabis, demonstrating strong demand for its products. HYTN is committed to maintaining high-quality standards through Good Manufacturing Practices to meet international market requirements.